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Edited by Angel NebredaAbstract The mitogen activated protein kinase (MAPK) fam-
ily, consisting of the extracellular signal regulated protein
kinase, c-Jun amino terminal MAPK and p38 subfamilies, is
conserved in evolution throughout the plant and animal king-
doms. These proteins have been implicated in diverse cellular
processes including cell growth, migration, proliferation, diﬀer-
entiation, survival and development. Gene-targeting approaches
in mice, chickens, frogs and zebraﬁsh revealed crucial roles of
MAPK in vertebrate development. Gene-disruption or -silencing
often lead to lethal eﬀects, therefore the zebraﬁsh ex utero devel-
opment provides an excellent in vivo model to study the function
of MAPK in early embryogenesis. In this review, we summarize
the current understanding of the MAPK family function in ver-
tebrate-development and place this into the perspective of possi-
bilities for future research.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The mitogen activated protein kinase (MAPK) family is con-
served in evolution and is involved in diverse cellular processes
including cell growth, proliferation, diﬀerentiation, survival,
innate immunity and development [1–3].Abbreviations: ASK1, apoptosis signal-regulating kinase 1; A-Raf1, V-
RAF murine sarcoma 3611 viral oncogene homolog 1; B-Raf, V-RAF
murine sarcoma viral oncogene homolog B1; BMK1, big MAP kinase
1; CLIC3, chloride intracellular channel 3; Cot, Cancer Osaka Thyroid
Oncogene (=Tpl-2); ERK, extracellular signal regulated protein kina-
se; JNK, c-Jun amino terminal MAPK; MEK, MAPK/ERK kinase;
MEKK, MEK kinase; MAPK, mitogen activated protein kinase; MK,
MAPK-activated protein kinases; MKK, MAPK kinase; MKKK,
MAPK kinase kinase; MLK2,3, mixed-lineage protein kinase 3; Mos,
V-MOS moloney murine sarcoma viral oncogene homolog; Myf5,
myogenic activator 5; POSH, plenty of SH3s; Raf1, V-RAF murine
leukemia viral oncogene homolog 1; SAPK, stress activated protein
kinase; Tpl-2, tumor progression locus 2; TAO1,2,3, thousand and one
amino acids; TAK1, TGFb activated kinase; v-src, avian Sarcoma
(Schmidt–Ruppin A-2) viral oncogene
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doi:10.1016/j.febslet.2006.08.025MAPKs transmit signals in the form of sequential phosphor-
ylation events. The phospho-relay system is composed of three
kinases: a MAPK kinase kinase (MAPKKK), a MAPK kinase
(MAPKK) and a MAPK. Phosphorylation of the MAPKs
occurs on a conserved dual-phosphorylation domain (Thr-Xxx-
Tyr) leads to activation of the protein (Fig. 1) and the subse-
quent formation of dimers which translocate into the nucleus
to activate downstream targets [1–3]. Three major subfamilies
of MAPK proteins have been deﬁned: extracellular signal
regulated kinases (ERK), the c-Jun amino-terminal kinases
(JNK), and the p38 MAP kinases. The middle amino-acid
residue of the conserved Thr-Xxx-Tyr dual-phosphorylation
domain designates a MAPK protein to one of these
subfamilies. In general, the ERK subfamily (TEY) is mainly
activated by growth factors, p38 (TGY) by stress factors and
JNK (TPY) are activated by stress-, diﬀerentiation- and
growth-factors [4–6]. It should be stressed here that scaﬀold
proteins play an important role in the spatial–temporal organi-
zation of signaling complexes leading to activation of a speciﬁc
cascade [1,6,7].
To illustrate the evolutionary conservation of the
MAPK family, we constructed a phylogenetic tree of the
vertebrate MAPKs by the neighbor-joining method (Fig. 2)
[8]. This analysis was performed by multiple alignments with
the amino acid sequences of the diﬀerent vertebrate MAPKs
from human, rat, mouse, Xenopus and zebraﬁsh. As expected
from the evolutional point of view the diﬀerent vertebrate
MAPKs cluster with their corresponding orthologs, which
are also indicated by their MAPK-family number (MAPK1–
15).
Currently, based on phosphorylation consensus, sequence
identity, signaling proﬁle and functions, six diﬀerent MAPK
cascades have been identiﬁed in mammals: ERK1/2, ERK3/
4, ERK5, ERK7/8, JNK1/2/3, and p38-isoforms a/b/
c(ERK6)/d [1–3] (Fig. 3). The best studied ERK1 and ERK2
are activated by the upstream MAPKKs MEK1 and MEK2,
while MEK1-2 are in turn activated by their upstream MAP-
KKKs or Raf protein kinases. Interestingly, ERK3 is a ubi-
quitously active MAPK and its activity is regulated by
protein stability. The mechanisms of regulation for ERK4
are still largely unclear. In addition, ERK5 is exclusively acti-
vated by MEK5, which can be phosphorylated by the MAP-
KKKs MEKK2 and MEKK3. ERK7 is similar to ERK3 in
that it is constitutively activated, presumably by the C-termi-
nus of the protein. ERK7 activity is not regulated by extracel-
lular stimuli. Despite intensive eﬀorts, the activators for ERK8
are yet unknown, although ERK8 is shown to be activated
after long stimulations with serum and in cells expressing the
oncogene v-src, suggesting that ERK8 is involved in long termblished by Elsevier B.V. All rights reserved.
Fig. 1. The mitogen activated protein kinase module. The MAPK
module consists of three kinases: a MAPKKK, a MAPKK and a
MAPK. Diﬀerent MAPK cascades can be activated by various signals.
Upon activation the upstream kinase activates the downstream kinase
by phosphorylation and leads to a response.
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range of MAPKKKs such as MEKK1-4, MLK2-3, apoptosis
signal-regulating kinase 1 (ASK1) and TGFb activated kinase
(TAK1). These activate the MAPKKs MEK3 and MEK6,
resulting in the activation of the p38 a, b, c, d isoforms. The
JNK MAPKs are activated by the MAPKKs MEK4 and 7,
which are in turn activated by the MAPKKKs MEKK1-4,
MLK2-3, TAO1-2, TAK1 and ASK1-2 [2,6,9,10]. Details of
the molecular mechanisms governing the developmental func-
tions of diﬀerent MAPK-cascades in vertebrate models are
beginning to emerge and will be discussed in the following sec-
tions (Figs. 2 and 3).2. ERK1/2
ERK1 (MAPK3, p44MAPK) was the ﬁrst identiﬁed MAPK
[11]. Until now, homologs for erk1 have been reported for
human, mouse, rat and zebraﬁsh genomes. ERK1 and ERK2
are the most intensively studied MAPKs in developmental
processes. Detailed immuno-histochemical analysis revealed
localized spatio-temporal patterns of ERK1/2 phosphorylation
during mouse [12], chicken and zebraﬁsh development, with
FGF as most predominant activator during development.
Erk1/ mice are viable, fertile and of normal size [13]. The
proliferation and maturation of the thymocytes is aﬀected,
despite expression of ERK2. Mice lacking ERK1 also manifest
abnormal signaling responses, which are linked to an upregu-
lation of ERK2 activity in the brain. ERK1 has a critical reg-
ulatory role in brain long-term adaptive changes underlyingstriatum-dependent behavioral plasticity and drug addiction
[14]. Furthermore, ERK1 is an important modulator of synap-
tic plasticity. The existence of the distinct scaﬀold MP1 for
ERK1-MEK1 indicates speciﬁc functions and location for
MEK1/ERK1 complex [15]. The MP1 scaﬀold was initially
identiﬁed by its capability to bind to the proline-rich region
of MEK1 and to be involved in the activation of ERK1, but
not ERK2 signaling [1,15].
ERK2 (MAPK1, p42MAPK) is found in human, mouse,
rat, frog, chicken and zebraﬁsh genomes. Importantly, mouse
embryos lacking exon 2 of the erk2 gene die in utero before
embryonic day (E) 8.5 due to a defect in trophoblast develop-
ment [16]. Erk2-deﬁcient mice fail to form the ectoplacental
cone and the extra-embryonic ectoderm, which gives rise to
mature trophoblasts in the fetus. In addition Erk2/ em-
bryos also fail to form mesoderm, based on histological criteria
at E6.5 and E7.5 [17,18]. Signiﬁcantly, ERK1 is incapable of
compensating for ERK2 function in erk2/ mice, suggesting
that the observed eﬀect is ERK2 speciﬁc and cannot be rescued
by ERK1.
Despite eﬀort, in frog and chicken no erk1 gene has been
found until now. However, the ERK1 protein has been de-
tected by Western-blot analysis in chicken, where p-ERK1/2
expression was observed in motor axons, but not in sensory
axons. In a follow up study Kato and co-workers have also
demonstrated speciﬁc activation of ERK1/2 in growing motor
axons suggesting that p-ERK1/2 may be involved in outgrowth
and/or guidance of this subset of axons [19]. In contrast, mod-
ulation of ERK2 activity aﬀects mesoderm diﬀerentiation in
Xenopus embryos, whereas inhibition of the ERK2 activation
prevents animal caps to diﬀerentiate into mesoderm tissues
[20]. Elevated ERK activation is also detected by immuno-
histochemistry during segmentation in mouse, chicken and
zebraﬁsh [21].
In zebraﬁsh, the presence of the ERK-MAPK cascade was
ﬁrst shown by Western-blot analysis, where insulin-like growth
factors (IGFs) stimulates zebraﬁsh cell proliferation by activat-
ing MAPK and PI3-kinase signaling pathways [22]. Subse-
quently it was shown that chitin oligosaccharides, activate
ERK1 and ERK2 in zebraﬁsh cells, via the Ras-Raf-MEK
module [23]. The developmental roles of ERK1 and ERK2
in zebraﬁsh development have mostly concentrated on the
functions of the FGF/MAPK pathway, which also contains
the inhibitors Sef [24,25], Sprouty2/4 and the MAPK phospha-
tases MKP1 and MKP3 [26]. Overactivation of the Fgf/ERK-
pathway leads to dorsalized embryos by inhibiting expression
of bmp genes [27]. Overexpression of ERK-MAPK phospha-
tase MKP3 or injection of a high dose of mRNA of the inhib-
itor Sef also results in an opposite ventralization [24,28]. This
implies that manipulation of ERK-MAPK activation aﬀects
zebraﬁsh development. It can therefore be suggested that
ERK1/2 in zebraﬁsh are regulated via canonical pathways,
but precise regulation and distinguished developmental func-
tion for ERK1 and ERK2 remain to be deﬁned. Recently, a
developmental role for ERK1 in axial mesoderm formation
was demonstrated and the absence of active ERK2 in the blas-
tula-margin blocked the initiation of epiboly cell migration,
disturbed the microtubule organization and led to an arrest
of embryogenesis, preventing further diﬀerentiation of epiblast
and hypoblast (unpublished data). Similarly to mice also in
zebraﬁsh ERK1 is not able to rescue developmental pheno-
types caused by ERK2 knock-down.
Fig. 2. Phylogenetic tree of the vertebrate MAPKs. The phylogenetic tree was constructed by the neighbor-joining method of the amino acid
sequences of the diﬀerent vertebrate MAPKs using Clustal W, available at the web server of the DNA Data Bank of Japan (DDBJ, http://
hypernig.nig.ac.jp). Clustal W analysis was done using default settings, without Kimura’s correction. Bootstrap sampling was reiterated 10000 times.
For the matrix table ‘blosum’ was used. The gap extension penalty was set at 0.2 and the gap distance was set at 8. Trees were printed using the
program Treeview (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html). The phylogenetic tree illustrates the evolutionary conservation of the
MAPK family members in human (h), rat (r), mouse (m), Xenopus laevis (x) and zebraﬁsh (z). The diﬀerent MAPKs cluster together and are indicated
by their MAPK-family number (MAPK1–15). Black text = previously annotated and shown to be expressed; gray text = translation of genomic
prediction. The predicted sequences were found in the following versions of the genomes of the Sanger Ensembl: Rattus norvegicus = v38,
Xenopus = v38; zebraﬁsh = Zv6.
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Interestingly, ERK3 and ERK4 are the only ERK-MAPKs
that lack the characteristic TEY activation motif, but display a
SEG activation domain (Fig. 3). Only the serine residue in this
SEG-motif can be phosphorylated. ERK3 has a characteristic
400 amino acid C-terminus, which is partly homologous to
ERK4 (170 amino acids). The stimulants for ERK3 and
ERK4 have not been identiﬁed, so far.
ERK3 (MAPK6, p97MAPK) has been reported for human,
mouse, rat, zebraﬁsh and gene-predictions were also found in
the frog and chicken genomes (Fig. 2). ERK3 seems to be
mainly regulated by its protein stability and auto-phosphoryl-
ation. Human ERK3 interacts with MAPK-activated protein
5 (MK5 or PRAK) and spatio-temporal expression of ERK3
and MK5 suggest co-expression of both kinases [29]. In mice,
deletion of mk5 leads to strong reduction of ERK3 protein lev-
els and is lethal around E11, the time-point where expression
levels of erk3 are maximal in wildtype mouse embryos
[29,30]. This suggests an universal role of this MK5-ERK3module in development. Erk3/ mice have been made,
although their phenotypes are not described in literature yet
(Turgeon B and Meloche S, manuscript in preparation) [29].
ERK4 (MAPK4, ERK3-related, ERK3-beta, p93MAPK),
closely related to ERK3 [31], was ﬁrst identiﬁed in human
[32], and subsequently described for mouse, rat, and zebraﬁsh.
A predicted ORF was also found in the chicken (Fig. 2). Its
spatio-temporal expression-pattern is predominantly localized
in the brain during zebraﬁsh development [33]. However, a
developmental function of this MAPK remains to be deter-
mined.4. ERK5 (MAPK7, BMK1)
ERK5, also referred to as big MAP kinase 1 (BMK1), is
found in human, mouse, rat, frog and zebraﬁsh. Activation
of ERK5 is mediated by MEK5. The ERK5 pathway is acti-
vated by oxidative stress, hyper-osmolarity and growth factors
[34]. ERK5 has a unique carboxy-terminal domain, which
Fig. 3. The mitogen activated protein kinase module and the developmental functions of the MAPK proteins. MAPK-modules can be activated by
various stimuli: mitogens (growth factors, cytokines), diﬀerentiation and stress factors (UV, osmolarity). The MAPK module consists of a
MAPKKK, a MAPKK and a MAPK. Two MAPKs (ERK3 and ERK7) are not activated by an upstream MAPKK, but are constitutive active and
are regulated by protein stability (indicated by an asterisk ). The MAPKs are subdivided into their corresponding subfamily, based on their dual
phosphorylation domain (dP-consensus). The functions, obtained by gene-targeting or -silencing studies, but also immuno-histochemistry, are
described for each MAPK. The lethality-index indicates if gene-disruption in mice resulted in a lethal developmental phenotype and at what day of
development ( = lethal, No = not lethal, ND = not determined). For erk3/ mouse the results are not published yet. The indicated lethality shown
for ERK3 (in white) is for MK5/ mice, a direct target of ERK3.
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2 (MEF2).
Genetic studies with ERK5- or MEK5-deﬁcient mice re-
vealed that the MEK5–ERK5 pathway is essential for blood
vessel development and cardiovascular development [35–40].
Mice that lack erk5 or mek5 die around E.10 due to defects
in placental development, angiogenesis and cardiovascular
development. Studies with conditional knockout, using the
inducible promoter Mx1 to direct Cre expression, revealed that
ablation of ERK5 in adult mice was lethal within 2–4 weeks
after induction of the Cre recombinase [41]. Histological and
in vitro analysis revealed that endothelial cells lost their integ-
rity, became round and eventually apoptotic. The loss of these
functional endothelial cells resulted in abnormally leaky blood
vessels and hemorrhages in multiple organs. These ﬁndings
indicate that survival of endothelial cells is MEK5 and
ERK5 dependent, and that the cardiovascular defects observed
in erk5/ and mek5/ embryos are due to the loss of endo-
thelial cells [41].
In Xenopus knockdown of ERK5 by antisense morpholino
injection inhibits neural diﬀerentiation and leads to growth
retardation in the head and eventually to reduced head struc-
tures [36]. In this system the activation of the MEK5–ERK5
pathway is necessary for neural diﬀerentiation in early embry-
onic development. It is likely that the observed inhibition ofneural diﬀerentiation may be one of the reasons for growth
retardation in the head region.
Controversially, studies with conditional brain speciﬁc
knockout mice, with Cre-expression controlled by the neuron
speciﬁc synapsin I or nestin promoters revealed that these mice
develop normally [37]. This might be due to species diﬀerential
functions for ERK5, the use of an inappropriate promoter in
the mouse model, or that a more global eﬀect is responsible
for the observed phenotypes in the brain after ERK5 knock-
down in the Xenopus. Furthermore, expression of erk5 is also
mainly localized in the zebraﬁsh brain and possibly a follow-up
study in zebraﬁsh will clarify developmental functions of
ERK5 [33].5. ERK7, ERK8 (MAPK15)
ERK7 (MAPK15) is found in rat, mouse and zebraﬁsh and
recently the Dictyostelium erkB (ERK2) has been characterized
as an erk7-ortholog [42,43]. Genome-based analyses revealed
that human erk8 and rodent erk7 are orthologs [44]. Further-
more, gene-predictions for erk7 were found within the chicken
and Xenopus genomes.
Like ERK3 and ERK5, the size of ERK7 and ERK8 is sig-
niﬁcantly larger than ERK1 and ERK2. Presumably, ERK7 is
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tic C-terminus [44]. Studies to determine their function in ver-
tebrate development have not yet been reported.6. JNK1,2,3 (MAPK9,10,11; SAPKc,a,b)
Activated JNKs phosphorylate the N-terminus of the c-Jun
protein and increases activity and stability of c-jun as a tran-
scription factor [45,46]. Both JNK activation and c-Jun phos-
phorylation regulate cell growth, whereas sustained JNK and
c-Jun activation following stress induces cell apoptosis, indi-
cating that the role of JNK in cell survival and death is com-
plex [47]. Mouse jnk1 and jnk2 are expressed ubiquitously
during development, whereas jnk3 is primarily expressed in
the brain and to a lesser extent in the heart and testis. Mice
lacking individual members of the jnk family are viable
[48,49]. The Jnk1/ knockout mice exhibited an aﬀected
T helper type-2 response, while T-cells from jnk2/ mice
showed impaired T helper type-1 diﬀerentiation. Both knock-
outs demonstrated defects in T cells activation and apoptosis
of thymocytes [50]. Mice lacking both of the ubiquitously ex-
pressed jnk isoforms (jnk1 and jnk2) die during mid-gastrula-
tion (around E.7) with neural tube closure and brain defects
[51]. Recently, it was shown that mice with a single allele of
jnk2 (jnk1/ jnk2/+), can survive to birth, but fail to close
the optic ﬁssure (retinal coloboma), a morphogenetic process
that resembles dorsal and thorax closure in Drosophila by reg-
ulating BMP expression [52]. Localization of p-JNK in the
spinal cord changes dramatically from cell-axons to the cell
nuclei during development in the chicken, suggesting physio-
logical functions of JNK during neuronal development [51].
In Xenopus oocytes initially two JNK isoforms, p40 JNK
and p49 JNK, were shown [53], but until now only one jnk-
gene (jnk1) is cloned in Xenopus. The ensemble genome project
of Xenopus tropicalis does predict a jnk3-gene. JNK activity
increases abruptly just prior to germinal vesicle breakdown
and is shown to be involved in the non-canonical Wnt pathway
to regulate Xenopus convergence and extension cell-move-
ments [54]. Furthermore, the active JNK signaling complex
formed by the scaﬀold protein POSH (Plenty of SH3s) and
the JNK-module is essential for the expression of anterior neu-
ral genes and apoptosis in Xenopus anterior development [55].
In zebraﬁsh also only one jnk-gene is described, which is
expressed throughout development and shows distinct tempo-
ral and spatial expression patterns [33], but the latest release of
the zebraﬁsh genome (Zv6) predicts a second jnk gene (Fig. 2).7. p38a,b,c,d (MAPK14,11,12,13)
The p38 family includes p38a (MAPK14, SAPK2a, CSBP),
p38b (MAPK11, SAPK2b), p38c (MAPK12, ERK6, SAPK3)
and p38d (MAPK12, SAPK4). Both p38a and p38b are widely
expressed isoforms that are involved in regulation of cell pro-
liferation, diﬀerentiation, development, and response to stress.
The p38a knockout mice are lethal due to defects in placental
angiogenesis [56,57]. In some genetic backgrounds, p38a dele-
tion results in a decrease of erythropoietin (Epo) production,
leading to anemia [58].
In Xenopus, the p38 MAPK signaling pathway is essential
for skeletal muscle diﬀerentiation in tissue culture models.Knockdown of p38 MAPK causes distinct defects in myogen-
esis in Xenopus laevis, showing that p38 MAPK is involved in
myogenesis during early development [59]. The zebraﬁsh p38a
otholog, p38a (MAPK14a), is asymmetrically activated on one
side of the blastodisc during the early cleavage period in zebra-
ﬁsh embryos. The use of a dominant negative form of p38a
revealed that asymmetric p38a activation is required for
symmetric and synchronous cleavage, and may be regulated
by the same machinery that controls the initiation of dorsaliza-
tion signals [60].
By screening with the rat erk3 gene, an erk6-clone was iso-
lated from a human skeletal muscle cDNA library, that
appeared to function as a signal transducer during diﬀerentia-
tion of myoblasts to myotubes [61]. Later it was found that
SAPK3 was identical to ERK6 [62,63]. Based on the phos-
phorylation domains and function, ERK6 is now classiﬁed
as p38c MAPK.
Mouse lacking p38b, p38c or p38d survive normally and do
not show any obvious phenotypes [9,64,65]. Also the p38c and
p38d double knockout mice was viable and fertile and had no
obvious health problems [65]. Despite the suggested role for
p38 MAPKs in inﬂammatory responses, these knockout mice
do not show pathological changes, indicating dispensable
physiological functions for p38b, p38c and p38d.
In frog, overexpression of a constitutively active mutant of
the p38 activator MKK6 accelerates progesterone-induced
maturation of Xenopus oocytes and was therefore suggested
to be involved in the meiotic maturation. Phosphorylation of
Cdc25C by p38c/SAPK3 is important for the meiotic G2/M
progression of Xenopus oocytes [66].
Information has been particularly limited regarding the
functional role of p38d (SAPK4). Eckert and coworkers de-
scribe p38d as a regulator of surface epithelia diﬀerentiation
and apoptosis [67]. Until now p38d is found to be expressed
in human, mouse and rat, but is not yet found in other verte-
brates. However, a genome search in zebraﬁsh (Zv6) and Xeno-
pus (v38) does predict a possible p38d-gene.8. Conclusions and perspectives
There is an increased understanding about the diﬀerent
MAPK pathways and their crucial roles in vertebrate develop-
ment. One of the striking observations is that some MAPKs
(ERK3 and ERK7) are not regulated by the dogmatic MAPK
module, but by protein stability. A major unresolved question
is why such a variety of MAPKs is needed. Gene-disruption
and -silencing experiments already showed central roles for
most of these proteins. These approaches often resulted in
early lethal eﬀects, but also revealed redundancy (Fig. 3).
The occurrence of redundancy can be addressed and overcome
by targeting multiple genes at the same time. Also further con-
ditional and tissue speciﬁc gene-targeting experiments will help
to understand the functions of the diﬀerent MAPKs. The use
of diﬀerent vertebrate model organisms and their speciﬁc ben-
eﬁcial characteristics will be helpful to achieve this goal. The
recent characterization of the zebraﬁsh mapk gene-family [33]
and its advantage to study early embryogenesis ex utero pro-
vides an excellent system for further investigation of the func-
tions of MAPKs in early development in vivo. The
transparency of zebraﬁsh embryos is of particular advantage
to explore the link of MAPKs to cell migration processes. This
S.F.G. Krens et al. / FEBS Letters 580 (2006) 4984–4990 4989has already resulted in the identiﬁcation of the role for ERK2
in developmental cell migration, additive to the well estab-
lished proliferation and diﬀerentiation functions.
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